REGENXBIO - Public Company Showcase at Ophthalmology Innovation Summit @ ASRS 2019
Ram Palanki, PharmD, SVP, Commercial Strategy and Operations speaks for REGENXBIO during the Public Company Showcase at OIS@ASRS 2019. REGISTER for our next ophthalmology conference today http://bit.ly/2yFA6cv. Ram Palanki, PharmD, SVP, Commercial Strategy and Operations for REGENXBIO, discusses the company’s gene therapy programs, which include 14 clinical stage product candidates in 20 partnered programs. Their NAV technology platform was created based on a search for AAV-vectors that were effective, as well as safe. The vectors in the company’s library provide higher and longer-term gene e…